Skip to main content

Published locations for No OS benefit with gefitinib vs. chemo for EGFR+ NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. No OS benefit with gefitinib vs. chemo for EGFR+ NSCLC

User login

  • Reset your password
  • /content/no-os-benefit-gefitinib-vs-chemo-egfr-nsclc
  • /fedprac/article/223669/lung-cancer/no-os-benefit-gefitinib-vs-chemo-egfr-nsclc
  • /oncologypractice/article/223669/lung-cancer/no-os-benefit-gefitinib-vs-chemo-egfr-nsclc
  • /fedprac/avaho/article/223669/lung-cancer/no-os-benefit-gefitinib-vs-chemo-egfr-nsclc
  • /hematology-oncology/article/223669/lung-cancer/no-os-benefit-gefitinib-vs-chemo-egfr-nsclc
  • /chestphysician/article/223669/lung-cancer/no-os-benefit-gefitinib-vs-chemo-egfr-nsclc